Age and serum lactate dehydrogenase level are independent prognostic factors in human immunodeficiency virus-related non-Hodgkin's lymphomas: A single-institute study of 96 patients

E. Vaccher, U. Tirelli, M. Spina, R. Talamini, D. Errante, C. Simonelli, A. Carbone

Research output: Contribution to journalArticle

Abstract

Purpose: The role of classical prognostic factors (ie, age, performance status [PS], stage, extranodal involvement, and serum lactate dehydrogenase [LDH] level) included in the International Index for diffuse large-cell non- Hodgkin's lymphoma (NHL) of the general population is presently unknown in the setting of human immunodeficiency virus (HIV). To assess the prognostic value of these factors in HIV-related NHL, we reviewed the cohort of patients with HIV-related NHL diagnosed and treated with combination chemotherapy (CT) at our institution. Patients and Methods: Ninety-six patients with systemic HIV-related NHL diagnosed and treated with combination CT regimens between September 1987 and December 1993 at the Centro di Riferimento Oncologico, Aviano, Italy, were studied. All clinical and laboratory data were evaluated by univariate and multivariate analyses, using overall survival as the end point. Results: Complete remission (CR) occurred in 48% of patients; the overall median survival and disease-free survival times were 7 and 13 months, respectively. Among the classical and HIV-related prognostic factors, the following had a statistically significant influence on survival: PS ≤ 2, elevated LDH level, age greater than 40 years, a CD4 cell count less than 100/μL, active opportunistic infections at diagnosis of NHL, and B symptoms. Multivariate analyses showed that only age, serum LDH level, and CD4 cell count were independent predictors of shortened survival. The increased hazard for patients greater than 40 years of age was 1.6 (95% confidence interval [CI], 1.2 to 2.3), for patients with increased LDH it was 1.8 (95% CI, 1.01 to 3.1), and for patients with a CD4 cell count less than 100/μL it was 1.7 (95% CI, 1.01 to 2.9). Conclusions: Our study shows that in addition to HIV-related prognostic factors, ie, CD4 cell count less than 100/μL, classical prognostic factors such as age and serum LDH level are independent prognostic factors and should be included in the design of future clinical trials of HIV-related NHL.

Original languageEnglish
Pages (from-to)2217-2223
Number of pages7
JournalJournal of Clinical Oncology
Volume14
Issue number8
Publication statusPublished - 1996

Fingerprint

L-Lactate Dehydrogenase
Non-Hodgkin's Lymphoma
HIV
CD4 Lymphocyte Count
Serum
Survival
Confidence Intervals
Combination Drug Therapy
Multivariate Analysis
Opportunistic Infections
Italy
Disease-Free Survival
Clinical Trials
Population

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Age and serum lactate dehydrogenase level are independent prognostic factors in human immunodeficiency virus-related non-Hodgkin's lymphomas : A single-institute study of 96 patients. / Vaccher, E.; Tirelli, U.; Spina, M.; Talamini, R.; Errante, D.; Simonelli, C.; Carbone, A.

In: Journal of Clinical Oncology, Vol. 14, No. 8, 1996, p. 2217-2223.

Research output: Contribution to journalArticle

@article{cece9517f31c4ecc8a2ad3e167796246,
title = "Age and serum lactate dehydrogenase level are independent prognostic factors in human immunodeficiency virus-related non-Hodgkin's lymphomas: A single-institute study of 96 patients",
abstract = "Purpose: The role of classical prognostic factors (ie, age, performance status [PS], stage, extranodal involvement, and serum lactate dehydrogenase [LDH] level) included in the International Index for diffuse large-cell non- Hodgkin's lymphoma (NHL) of the general population is presently unknown in the setting of human immunodeficiency virus (HIV). To assess the prognostic value of these factors in HIV-related NHL, we reviewed the cohort of patients with HIV-related NHL diagnosed and treated with combination chemotherapy (CT) at our institution. Patients and Methods: Ninety-six patients with systemic HIV-related NHL diagnosed and treated with combination CT regimens between September 1987 and December 1993 at the Centro di Riferimento Oncologico, Aviano, Italy, were studied. All clinical and laboratory data were evaluated by univariate and multivariate analyses, using overall survival as the end point. Results: Complete remission (CR) occurred in 48{\%} of patients; the overall median survival and disease-free survival times were 7 and 13 months, respectively. Among the classical and HIV-related prognostic factors, the following had a statistically significant influence on survival: PS ≤ 2, elevated LDH level, age greater than 40 years, a CD4 cell count less than 100/μL, active opportunistic infections at diagnosis of NHL, and B symptoms. Multivariate analyses showed that only age, serum LDH level, and CD4 cell count were independent predictors of shortened survival. The increased hazard for patients greater than 40 years of age was 1.6 (95{\%} confidence interval [CI], 1.2 to 2.3), for patients with increased LDH it was 1.8 (95{\%} CI, 1.01 to 3.1), and for patients with a CD4 cell count less than 100/μL it was 1.7 (95{\%} CI, 1.01 to 2.9). Conclusions: Our study shows that in addition to HIV-related prognostic factors, ie, CD4 cell count less than 100/μL, classical prognostic factors such as age and serum LDH level are independent prognostic factors and should be included in the design of future clinical trials of HIV-related NHL.",
author = "E. Vaccher and U. Tirelli and M. Spina and R. Talamini and D. Errante and C. Simonelli and A. Carbone",
year = "1996",
language = "English",
volume = "14",
pages = "2217--2223",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "8",

}

TY - JOUR

T1 - Age and serum lactate dehydrogenase level are independent prognostic factors in human immunodeficiency virus-related non-Hodgkin's lymphomas

T2 - A single-institute study of 96 patients

AU - Vaccher, E.

AU - Tirelli, U.

AU - Spina, M.

AU - Talamini, R.

AU - Errante, D.

AU - Simonelli, C.

AU - Carbone, A.

PY - 1996

Y1 - 1996

N2 - Purpose: The role of classical prognostic factors (ie, age, performance status [PS], stage, extranodal involvement, and serum lactate dehydrogenase [LDH] level) included in the International Index for diffuse large-cell non- Hodgkin's lymphoma (NHL) of the general population is presently unknown in the setting of human immunodeficiency virus (HIV). To assess the prognostic value of these factors in HIV-related NHL, we reviewed the cohort of patients with HIV-related NHL diagnosed and treated with combination chemotherapy (CT) at our institution. Patients and Methods: Ninety-six patients with systemic HIV-related NHL diagnosed and treated with combination CT regimens between September 1987 and December 1993 at the Centro di Riferimento Oncologico, Aviano, Italy, were studied. All clinical and laboratory data were evaluated by univariate and multivariate analyses, using overall survival as the end point. Results: Complete remission (CR) occurred in 48% of patients; the overall median survival and disease-free survival times were 7 and 13 months, respectively. Among the classical and HIV-related prognostic factors, the following had a statistically significant influence on survival: PS ≤ 2, elevated LDH level, age greater than 40 years, a CD4 cell count less than 100/μL, active opportunistic infections at diagnosis of NHL, and B symptoms. Multivariate analyses showed that only age, serum LDH level, and CD4 cell count were independent predictors of shortened survival. The increased hazard for patients greater than 40 years of age was 1.6 (95% confidence interval [CI], 1.2 to 2.3), for patients with increased LDH it was 1.8 (95% CI, 1.01 to 3.1), and for patients with a CD4 cell count less than 100/μL it was 1.7 (95% CI, 1.01 to 2.9). Conclusions: Our study shows that in addition to HIV-related prognostic factors, ie, CD4 cell count less than 100/μL, classical prognostic factors such as age and serum LDH level are independent prognostic factors and should be included in the design of future clinical trials of HIV-related NHL.

AB - Purpose: The role of classical prognostic factors (ie, age, performance status [PS], stage, extranodal involvement, and serum lactate dehydrogenase [LDH] level) included in the International Index for diffuse large-cell non- Hodgkin's lymphoma (NHL) of the general population is presently unknown in the setting of human immunodeficiency virus (HIV). To assess the prognostic value of these factors in HIV-related NHL, we reviewed the cohort of patients with HIV-related NHL diagnosed and treated with combination chemotherapy (CT) at our institution. Patients and Methods: Ninety-six patients with systemic HIV-related NHL diagnosed and treated with combination CT regimens between September 1987 and December 1993 at the Centro di Riferimento Oncologico, Aviano, Italy, were studied. All clinical and laboratory data were evaluated by univariate and multivariate analyses, using overall survival as the end point. Results: Complete remission (CR) occurred in 48% of patients; the overall median survival and disease-free survival times were 7 and 13 months, respectively. Among the classical and HIV-related prognostic factors, the following had a statistically significant influence on survival: PS ≤ 2, elevated LDH level, age greater than 40 years, a CD4 cell count less than 100/μL, active opportunistic infections at diagnosis of NHL, and B symptoms. Multivariate analyses showed that only age, serum LDH level, and CD4 cell count were independent predictors of shortened survival. The increased hazard for patients greater than 40 years of age was 1.6 (95% confidence interval [CI], 1.2 to 2.3), for patients with increased LDH it was 1.8 (95% CI, 1.01 to 3.1), and for patients with a CD4 cell count less than 100/μL it was 1.7 (95% CI, 1.01 to 2.9). Conclusions: Our study shows that in addition to HIV-related prognostic factors, ie, CD4 cell count less than 100/μL, classical prognostic factors such as age and serum LDH level are independent prognostic factors and should be included in the design of future clinical trials of HIV-related NHL.

UR - http://www.scopus.com/inward/record.url?scp=0029841888&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029841888&partnerID=8YFLogxK

M3 - Article

C2 - 8708710

AN - SCOPUS:0029841888

VL - 14

SP - 2217

EP - 2223

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 8

ER -